Articles by Daniel Marsh
3i Group Plunges to Year Low on Action Growth Fears
3i Group shares fell to a new 52-week low, trading below estimated net asset value, as doubts mount over the growth trajectory of its primary holding, Action.
Major Funds Disclose Beazley Stakes as Zurich's $11 Billion Bid Progresses
Wellington Management, Vanguard, and Polar Capital have disclosed significant stakes in Beazley Plc after Zurich Insurance's £8.1 billion takeover bid. Beazley shares currently trade 3.4% below the offer price.
Sunbelt Rentals Launches $1.5B Buyback Following NYSE Listing
Sunbelt Rentals Holdings has begun its $1.5 billion share repurchase program, acquiring 663,882 shares worth approximately £36.2 million in the first week following its primary listing shift to the New York Stock Exchange.
UK Mortgage Rates Climb as Rate Cut Expectations Evaporate
Major UK lenders, including NatWest and Barclays, are increasing mortgage rates for both new and existing customers, reversing a brief period of declines. The average two-year fixed rate has risen to 4.84%, while mortgage approvals have fallen to a two-year low.
Unilever Stock Dips Amid Oil Spike, Renewing Focus on Post-Spin-Off Growth
Unilever's stock declined in London trading as a sharp rise in crude oil prices triggered a broad market selloff. Investors are scrutinizing the company's growth trajectory after its recent strategic spin-off and a warning that 2026 sales may hit the low end of its target range.
Rolls-Royce Deepens Polish Defense Partnership Amid European Arms Surge
Rolls-Royce has entered a preliminary agreement with Poland's state-backed defense group PGZ to broaden collaboration on propulsion systems for military land and sea platforms. The move aligns with a significant increase in European arms imports and Poland's push to access EU military funding.
BlackRock Fund Limits Spark Liquidity Fears as Private Credit Defaults Hit Record
BlackRock has restricted redemptions from its $26 billion private-credit fund after requests surged, intensifying stress in real estate-linked markets. Fitch warns of record defaults in the sector.
Pfizer's Eczema Candidate Tilrekimig Advances, Eyes Dupixent Rivalry
Pfizer announced its experimental eczema drug tilrekimig achieved its main goal in a mid-stage study, showing significant symptom improvement. The company plans to initiate a pivotal Phase 3 trial later this year.
U.S. Art Auction Sales Surge 23% in 2025, Led by Established Artists
U.S. art auction sales at top houses rose 23% to $3.17 billion in 2025, the first annual gain since 2022, according to Bank of America. The rebound was fueled by historical artists and a focus on quality.
FTSE 100 Recovers from Sharp Drop as Oil Price Spike Roils London
London's FTSE 100 pared steep early losses to close 0.3% lower on Monday, while the FTSE 250 fell 1.6%. A dramatic spike in oil prices above $119 a barrel, driven by Middle East conflict, triggered a broad market sell-off and renewed stagflation fears.